3-[(3As,6Ar)-5-{5-Chloro-2-[(1-Methyl-1H-Pyrazol-4-Yl)Amino]Pyrimidin-4-Yl}-3A-Methylhexahydropyrrolo[3,4-C]Pyrrol-2(1H)-Yl]-3-Oxopropanenitrile

1 trials 1 recruiting

Filter these 1 trials by condition, phase, country and more.

Open in Search →

1 Registered trials

1 Recruiting

0 Completed trials

1 Sponsors

5 Countries

Phase II

Phase II: 1

Sponsors using this IMP

Innocare Pharma Inc. 1

All trials

1 total

A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of the Efficacy and Safety of ICP-332 in Participants with Pruri… Recruiting

2025-523404-74-00 Phase II 5 countries Innocare Pharma Inc.

Showing 1–1 of 1 trials

← All drugs A–Z